Mr. Xiaorong, Gao：
Doctoral Supervisor in the Department of Biomedical Engineering at Tsinghua University School of Medicine, and one of the first batch of Tenure Professors at Tsinghua University.
The primary research field is neuroengineering, specifically focusing on the current international research hotspot of brain-computer interfaces (BCI). The Tsinghua University Neuroengineering Laboratory, led by this professor, is at the forefront in China and advanced internationally in the field of brain-computer interfaces, recognized as an active research institution globally in this area.
Building on theoretical research achievements, in 2000, the professor proposed and developed a brain-computer interface technology based on steady-state evoked potentials, having obtained patents in the United States and China as the first inventor. This technology is at the world-leading level in non-invasive brain-computer interfaces. In 2011, a vision-based brain-computer interface utilizing coded stimulation was proposed and realized.

Mr. Tao Zheng：
Chairman and General Manager of Cnano Technology (688116). Dr. Zheng studied at Nanjing University from 1984 to 1988, where he obtained his Bachelor's degree in Physics. He attended the University of Toronto from 1991 to 1993, earning a Master's degree in Physics. From 1993 to 1996, he studied at Simon Fraser University and received his Ph.D. in Physics. In October 1995, Dr. Zheng published a paper titled “Mechanisms for Lithium Insertion in Carbonaceous Materials” in the journal Science. He conducted postdoctoral research in the Physics Department at Dalhousie University from August 1996 to May 1997.
Since 1997, Dr. Zheng held positions at Telcordia/Bellcore, Voltix Technology Ltd, and A123 Systems. Since January 2011, he founded Cnano Technology, serving as the Chairman and General Manager. In November 2011, he was recognized by the Jiangsu Provincial Talent Work Leadership Group under the "Jiangsu Province High-Level Innovative and Entrepreneurial Talents Introduction Plan". In December 2012, he was acknowledged as a leading talent of the "Innovative Team Plan" introduced team by the Jiangsu Provincial Talent Work Leadership Group. In March 2017, Dr. Zheng was honored by the Jiangsu Provincial People's Government with the title of Advanced Individual for Outstanding Contributions to Manufacturing in Jiangsu Province.

Mr Xiao, Shen：
A distinguished figure among Guangdong Province's Top 100 Doctoral and Post-Doctoral Innovative Personalities, a leading member of the "Pearl River Talent Plan" for introducing innovative entrepreneurial teams, and the Vice-Chairman of the Pharmaceutical Engineering Committee of the Guangdong Pharmaceutical Association.
In 2016, he established Guangzhou Cantonbio Co., Ltd. The company possesses a domestically leading one-stop development platform for biopharmaceutical CMC, which includes antibody optimization, cell line construction and development, upstream and downstream process development, analytical method development, formulation process development, technology and quality inspection method transfer, pilot and commercial production, clinical bioanalysis, clinical supply services, and quality assurance. It operates internationally as a biopharmaceutical CDMSO company, classified as a national specialized, distinctive, innovative, and small but potent enterprise.